Clinical Trial

Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-27.
Trial Details
NCT Number NCT07562399
Lead Sponsor Dana-Farber Cancer Institute
Conditions Medication Adherence, Breast Cancer
Enrollment 224 participants
Start Date 2026-09-20
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-20